Jonas Jutzi is a postdoctoral fellow at Brigham and Women’s Hospital in Boston under the mentorship of the Scholar of The Leukemia & Lymphoma Society Dr. Ann Mullally. Dr. Jutzi received his MD and PhD, from the University of Freiburg, Germany. His achievements include publications in JEM and Blood describing mutations in NFE2 and unravelling their role in myeloproliferative neoplasms (MPN). Dr. Jutzi’s translational focus also provided preclinical evidence of the efficacy of the drug bomedemstat in MPN, which is currently under clinical investigation. Dr. Jutzi has been awarded several research awards, including the prize for the best medial dissertation by the German Society of Hematology and Oncology. He also participated in the prestigious Translational Research Training in Hematology that fosters scientists through a yearlong mentoring program. His goal is to build an independent laboratory with the support of this Special Fellowship by the The Leukemia & Lymphoma Society.